Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Prime Medicine (PRME) Other Operating Expenses (2023)

Historic Other Operating Expenses for Prime Medicine (PRME) over the last 1 years, with Q4 2023 value amounting to $13.5 million.

  • Prime Medicine's Other Operating Expenses changed N/A to $13.5 million in Q4 2023 from the same period last year, while for Sep 2024 it was $13.5 million, marking a year-over-year change of. This contributed to the annual value of $13.5 million for FY2023, which is N/A changed from last year.
  • Per Prime Medicine's latest filing, its Other Operating Expenses stood at $13.5 million for Q4 2023.
  • Prime Medicine's 5-year Other Operating Expenses high stood at $13.5 million for Q4 2023, and its period low was $13.5 million during Q4 2023.